| __timestamp | Arrowhead Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 55402000 |
| Thursday, January 1, 2015 | 382000 | 66107000 |
| Friday, January 1, 2016 | 158333 | 103402000 |
| Sunday, January 1, 2017 | 31407709 | 135736000 |
| Monday, January 1, 2018 | 16142321 | 245116000 |
| Tuesday, January 1, 2019 | 168795577 | 108935000 |
| Wednesday, January 1, 2020 | 87992066 | 156000000 |
| Friday, January 1, 2021 | 138287000 | 214957000 |
| Saturday, January 1, 2022 | 232810000 | 143418000 |
| Sunday, January 1, 2023 | 240735000 | 96265000 |
| Monday, January 1, 2024 | 3551000 |
Unleashing insights
In the dynamic world of pharmaceuticals, understanding financial trends is crucial. This chart highlights the gross profit trajectories of Arrowhead Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Arrowhead Pharmaceuticals has shown a remarkable growth, with its gross profit surging by over 137,000% from 2014 to 2023. In contrast, Ligand Pharmaceuticals experienced a more fluctuating trend, peaking in 2018 with a gross profit of approximately 245 million, before declining to around 96 million in 2023.
Arrowhead's consistent upward trend, especially post-2017, reflects its strategic advancements and market positioning. Meanwhile, Ligand's volatility suggests a need for strategic recalibration. Notably, data for 2024 is incomplete, indicating potential shifts in the coming year. This analysis provides a snapshot of the competitive landscape, offering insights into the financial health and strategic directions of these pharmaceutical giants.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Catalent, Inc. vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends